|Tuesday, December 17, 2019|
|12:30 PM - 01:30 PM ET|
From CRISPR-Cas9 to iPSCs and mRNA inhibitors, cell and gene therapies represent the cutting edge of innovation. While this exciting and rapidly developing field continues to revolutionize the pharmaceutical and biotechnology industry, it also presents unique legal and regulatory challenges. Please join us for a discussion of some of the key legal and regulatory issues impacting the cell and gene therapy space.
For more information, please contact Erin Beck.
CLE credit: CLE credit in CA, IL, MA, NJ, NY, PA, TX, and VA is currently pending approval.